Latanoprost Neon Healthcare

Latanoprost, the active ingredient in Latanoprost Neon Healthcare, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is employed in the management of open‑angle glaucoma and ocular hypertension in adult patients, helping to preserve visual function through daily administration.

GNH USA supplies Latanoprost Neon Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Latanoprost is a prostaglandin analog used to reduce intra‑ocular pressure in glaucoma‑related conditions. - Open-angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers eye pressure to prevent development of glaucoma.

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eye irritation: transient burning or stinging. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual increase in brown pigmentation.

Serious or Rare Side Effects: - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea. - Vision loss: sudden decrease in visual acuity.

When prescribing Latanoprost, clinicians should consider the following precautions to ensure safe use. - Contraindication: avoid in patients with known hypersensitivity to latanoprost or any component of the formulation. - Caution: monitor patients with a history of uveitis or ocular inflammation. - Pregnancy: safety not established; use only if potential benefit justifies risk. - Breastfeeding: unknown excretion; weigh benefits against potential infant exposure. - Contact lens wear: discontinue use or remove lenses before instillation to prevent discoloration. - Store at room temperature: keep below 25°C, in original container, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents; awareness of these interactions helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory eye drops: may diminish pressure‑lowering effect. - Prostaglandin analog antagonists: counteract latanoprost activity.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive intra‑ocular pressure reduction; monitor for hypotony. - Carbonic anhydrase inhibitors: potential enhanced pressure lowering. - Systemic prostaglandin analogs: may increase risk of ocular side effects.